Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient diagnostic test sequence: applications of the probability-modifying plot.

J L Severens1, G Sonke, R J Laheij

  • 1Medical Department of Technology Assessment (253 MTA), University Medical Centre, St. Radboud, 6500 HB Nijmegen, The Netherlands. h.severens@mie.kun.nl

Journal of Clinical Epidemiology
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed.

Breast cancer research and treatment·2023
Same author

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Systematic reviews as a "lens of evidence": Determinants of participation in breast cancer screening.

Journal of medical screening·2020
Same author

What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews.

Systematic reviews·2017
Same author

The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes.

Medical oncology (Northwood, London, England)·2017

Physicians can optimize diagnostic testing strategies by considering cost-effectiveness. The probability-modifying plot helps identify the most economical sequence of tests without compromising clinical accuracy for conditions like Helicobacter pylori and benign prostatic hyperplasia.

Area of Science:

  • Medical Decision Making
  • Health Economics
  • Diagnostic Test Evaluation

Background:

  • Excessive diagnostic testing often fails to achieve definitive disease status certainty.
  • Healthcare budget constraints necessitate cost-effective diagnostic approaches.
  • The diminishing marginal gain of sequential tests requires careful consideration of costs versus benefits.

Purpose of the Study:

  • To develop a method for determining economically efficient diagnostic testing sequences.
  • To maintain clinical effectiveness while optimizing testing strategies.
  • To visualize and calculate the economic efficiency of various test orders.

Main Methods:

  • Development of the probability-modifying plot.
  • Application of the model to diagnose Helicobacter pylori infection.

Related Experiment Videos

  • Application of the model to diagnose benign prostatic hyperplasia.

    • Main Results:

    • The probability-modifying plot visualizes the economic efficiency of all potential test sequences.
    • Identified that different test sequences can have equal diagnostic accuracy but varying costs.
    • Demonstrated a method to select the most cost-effective testing strategy.

    Conclusions:

    • The probability-modifying plot is an effective tool for optimizing diagnostic test sequences.
    • Economic efficiency can be improved without sacrificing clinical effectiveness in diagnostic strategies.
    • Physicians can utilize this tool to make more informed decisions regarding patient testing within budget limitations.